Blog

  • All Post
  • Drug Information
  • General
  • Latest Drug Alerts
  • News & Updates
  • Reporting Side Effects
Improving Patient Safety in Vascular Access: The Critical Role of Individualization and Patient Preferences

January 1, 2026

Hemodialysis vascular access is often termed the “lifeline” of patients with end-stage renal disease. However, due to frequent complications, it is also considered the “Achilles heel” of hemodialysis therapy. While traditional patient safety efforts have focused on clinician training and patient education, this chapter advocates for a transformative approach—one that prioritizes individualization of care and active...

What Every Doctor Should Know about Drug Safety in Patients with Chronic Kidney Disease

December 30, 2025

Chronic Kidney Disease (CKD) significantly alters the pharmacokinetics and pharmacodynamics of many drugs, making medication management a critical aspect of patient care. In the context of dialysis access procedures—such as central venous catheter insertion or arteriovenous fistula placement—drug safety becomes even more paramount. This article synthesizes key recommendations and evidence-based practices from the...

EDA Renal Anaemia Guidance to Good Pharmacy Practice

December 26, 2025

This document is the "EDA Renal Anaemia Guidance to Good Pharmacy Practice" (Code: EDREX:GU.CAP.Care.016, Version: 2025), issued by the Egyptian Drug Authority's Central Administration of Pharmaceutical Care. It serves as a comprehensive, evidence-based clinical practice guideline for the management of anemia in patients with Chronic Kidney Disease (CKD).

See More

End of Content.

Advancing Medication Safety Through Knowledge and Vigilance

2025 © AlVigiLance

Powered by SiraLance